Route1 Files Complaint against AirWatch LLC for Patent Infringement
Provides an update on U.S. government MobiKEY renewals
CloudJumper Launches JumpStart for Fast Ground to Cloud Customer Onboarding to WaaS
Company Powers Channel Partners with Limited Touch Customer Onboarding Solution to Improve Efficiency and Enhance Profitability
Capriza Achieves Highest Possible Rating for Customer Feedback in New Report by Independent Research Firm
Enterprise Mobility Leader Scores a Five/Five in Customer Feedback Criteria in Low-code Mobile Development Platforms Evaluation
Oversight Systems Partners with Acquis Consulting to Improve Management of Travel & Expense Programs
Implementation Experience Combined with Advanced Analytics Allows Companies to Make Smarter Business Decisions
Rapoo Enters North American Market
Global Manufacturer Introduces Affordable 5G Wireless Peripheral Products
Brocade Extends Gen 6 Fibre Channel Portfolio with a No-Compromise Entry-Level Switch and Industry-First Virtual Machine Visibility for Storage Networks
Delivers up to 32 Gbps Performance, Simplicity and Proven Reliability for All-Flash Data Centers
Entrepreneur and “Shark” Daymond John to Keynote Host Analytics World 2017
Self-Made Success to Discuss his Journey and Lessons Learned at EPM Event of the Year
Epazz, Inc. Eliminates Toxic Debt, Ends Toxic Financing and has Paid off Toxic Convertible Debt
CHICAGO, IL — (Marketwired) — 03/28/17 — . (OTC PINK: EPAZ), a leading provider of cloud-based business software solutions, has announced the following updates for shareholders regarding the Company–s business direction as well as efforts to eliminate toxic debt.The Company has taken on no new debt in the last year from toxic lenders and is committed to using other funding instruments, which will not include toxic terms. The Company has no debt with any of the convertible debt lenders such
Signal Announces First Enterprise-Wide Customer Identity Solution
Independent solution empowers brands to connect and leverage identity beyond advertising
Zenosense, Inc.: MIDS Medical Engages Future Diagnostics for Assay Consulting Services
VALENCIA, SPAIN — (Marketwired) — 03/28/17 — Zenosense, Inc. (OTCQB: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac, a Point of Care ("POC") handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition of patients reporting chest pain and with suspected acute myocardial infarct